The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...

The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...

GRMN's expanding portfolio makes the stock worth investing. However, stretched valuation keeps investors on the sidelines.

Scaling GLP-1 manufacturing capacity remains a key priority for the pharma industry, to help supply catch up with the ...

With thousands of press releases published each week, it can be difficult to keep up with everything on . To help ...

Temu and Pinduoduo retail apps have exploded in China and internationally thanks to bargain-basement pricing. But a potential ...

Garmin launched its new Lily 2 Active watch, a petite device boasting a 1 x 0.84-inch display, two physical buttons, and a ...

Dylan is the Coronado ASB President and dedicates much of his after-school time to this position. He has played for the ...

LEBANON, Ind. (WFFT) — Eli Lilly and Company announced another $4.5 billion investment in Lebanon’s LEAP Research and ...

President Biden and Vice President Kamala Harris raced to the Southeast on Wednesday to survey the storm damage from ...

Garmin’s smallest smartwatch with built-in GPS has launched. The Lily 2 Active is undeniably stylish and fit for anyone who ...